By NewsDesk  @infectiousdiseasenews Seqirus announced this week that the U.S. Food and Drug Administration (FDA) has approved the first adjuvanted quadrivalent influenza vaccine, FLUAD® QUADRIVALENT...

Influenza viruses typically circulate in the United States annually, most commonly from late fall through early spring. Most persons who contract influenza will recover without sequelae. However, influenza...

Seqirus announced this week that the US Food and Drug Administration (FDA) has approved FLUCELVAX QUADRIVALENT™ (Influenza Vaccine), the first four-strain, cell culture-derived, inactivated seasonal...

By

The World Health Organization (WHO) released the following statement yesterday concerning the global influenza situation and the serious public health implications involved: The current global influenza...